在使用TriNetX的回顾性队列研究中分析临床实验室数据结果
Joshua Wang1, Kuo-Wang Tsai1, Chien-Lin Lu2,3
1Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Biochemia medica
|August 18, 2025
概括
这项研究解决了TriNetX平台分析临床实验室数据的局限性. 它为研究人员提供解决方案,以有效地查询纵向实验室结果,以进行回顾性队列研究.
科学领域:
- 生物医学信息学 生物医学信息学
- 临床研究信息学 临床研究信息学
- 健康 数据科学 数据科学
背景情况:
- TriNetX是一个全球网络的匿名患者数据,用于回顾性队列研究.
- 目前的TrinetX功能仅限于查询实验室数据,只提供最新的测试结果.
- 这限制了在多个时间点收集的实验室数据的分析.
研究的目的:
- 引入创新的,基于数据的解决方案,以克服TrinetX在查询纵向实验室数据方面的局限性.
- 为使用TriNetX进行临床实验室数据分析的研究人员提供实际指导.
- 增强TrinetX的实用性,用于涉及时间序列实验室测量的详细回顾性研究.
主要方法:
- 开发针对TrinetX数据结构的新查询策略.
- 实施方法来汇总和分析实验室结果跨多个时间点在一个患者队列.
- 在TriNetX环境中使用模拟或真实世界的临床数据验证拟议的解决方案.
主要成果:
- 证明能够检索和分析历史实验室测试结果,超出最近的输入.
- 量化了新方法对纵向研究队列识别和表征的影响.
- 为研究人员提供了一个框架,以便在TriNetX中对实验室数据进行更复杂的分析.
结论:
- 提出的解决方案显著提高了TrinetX分析纵向临床实验室数据的能力.
- 研究人员现在可以在 TriNetX.X 中使用多时间点实验室数据进行更全面的回顾性研究.
- 这些进步提高了TrinetX在需要详细时间实验室数据分析的临床研究中的价值.
相关概念视频
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Statistical Software for Data Analysis and Clinical Trials
784
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
784
Statistical Methods for Analyzing Epidemiological Data
532
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
532
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382


